Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05745038 · ClinicalTrials.gov registry record · NA

A Single Arm Pilot Trial of a Social Network Intervention

A NA study of Cancer, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
330
Enrollment target
1
Study location

NCT05745038: Recruiting NA study of Cancer, sponsored by University of Rochester.

NCT05745038 is a NA study of Cancer that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 330 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05745038, a NA study of Cancer, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
330 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if a social network support program (SOcial Networks to Activate Trust \& Adherence or SONATA) is helpful for older individuals receiving cancer treatment. The SONATA program will last for about 4 months. There are a total of 6 coaching sessions. The first 5 sessions will be held approximately every 1 to 2 weeks. Session 6 or the final session will be held approximately 1 to 2 months after session 5. Each session will last for about 1 to 2 hours.

Primary Outcome

Number of patients approached who consent

Conditions Studied

Interventions

  • BEHAVIORAL SONATA

Study Locations (1)

New York

  • University of Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 330 participants
Start Date 2023-11-29
Est. Completion 2028-06-30
Phase NA
University of Rochester

636 total trials

What NCT05745038 shows while recruiting

NCT05745038 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which SONATA is the first listed.

NCT05745038 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05745038 about?

NCT05745038 is a clinical study titled "A Single Arm Pilot Trial of a Social Network Intervention". The purpose of this study is to see if a social network support program (SOcial Networks to Activate Trust \& Adherence or SONATA) is helpful for older individuals receiving cancer treatment. The SONATA program will last for about 4 months. There are a total of 6 coaching sessions. The first 5 sessi...

What is the current status of trial NCT05745038?

This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2023-11-29. Estimated completion is 2028-06-30.

What conditions does trial NCT05745038 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05745038?

The interventions under investigation include: SONATA (BEHAVIORAL).

Who is sponsoring clinical trial NCT05745038?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05745038 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05745038's enrollment target sits among peer trials

330 172nd of 615 higher than 444 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00359684 · 330 participants

    Use of Cysteamine in the Treatment of Cystinosis

  • NCT03817502 · 330 participants · Phase 3

    Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  • NCT03922724 · 330 participants · Phase 2

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

  • NCT03932773 · 330 participants · NA

    Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05745038, the US trial registry maintained by the National Library of Medicine. NCT05745038 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.